Sage Therapeutics (SAGE) PT Raised to $89 at RBC Capital as the Company Heads into a Tranformative Year
Tweet Send to a Friend
RBC Capital analyst Brian Abrahams raised the price target on Sage Therapeutics (NASDAQ: SAGE) to $89.00 (from $86.00) after the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
